| Primary |
| Pleural Mesothelioma Malignant |
18.3% |
| Gastric Cancer |
15.0% |
| Oesophageal Carcinoma |
9.3% |
| Ovarian Cancer |
9.0% |
| Hypopharyngeal Cancer |
5.7% |
| Small Cell Lung Cancer Stage Unspecified |
4.6% |
| Cervix Carcinoma |
3.8% |
| Testis Cancer |
3.8% |
| Cervix Carcinoma Recurrent |
3.5% |
| Bone Sarcoma |
3.3% |
| Medulloblastoma |
3.3% |
| Nausea |
3.0% |
| Constipation |
2.7% |
| Decreased Appetite |
2.7% |
| Lung Neoplasm Malignant |
2.5% |
| Non-small Cell Lung Cancer |
2.2% |
| Febrile Neutropenia |
1.9% |
| Lung Adenocarcinoma |
1.9% |
| Premedication |
1.9% |
| Back Pain |
1.6% |
|
| White Blood Cell Count Decreased |
22.1% |
| Renal Impairment |
10.6% |
| Vomiting |
5.8% |
| Abdominal Pain Upper |
4.8% |
| Sepsis |
4.8% |
| Acute Myeloid Leukaemia |
3.8% |
| Anaphylactic Shock |
3.8% |
| Deep Vein Thrombosis |
3.8% |
| Ileus |
3.8% |
| Myelodysplastic Syndrome |
3.8% |
| Oedema Peripheral |
3.8% |
| Pharyngeal Stenosis |
3.8% |
| Renal Failure |
3.8% |
| Subileus |
3.8% |
| Interstitial Lung Disease |
2.9% |
| Laryngopharyngitis |
2.9% |
| Nausea |
2.9% |
| Pneumonitis |
2.9% |
| Pulmonary Infarction |
2.9% |
| Rash |
2.9% |
|
| Secondary |
| Testicular Mass |
11.4% |
| Gastric Cancer |
9.5% |
| Hodgkin's Disease |
7.6% |
| Testis Cancer |
7.1% |
| Bone Sarcoma |
5.7% |
| Oropharyngeal Cancer Recurrent |
5.7% |
| Oropharyngeal Cancer Stage Unspecified |
5.7% |
| Prophylaxis |
5.7% |
| Lung Neoplasm Malignant |
5.2% |
| Pyrexia |
5.2% |
| Chemotherapy |
4.8% |
| Peripheral Sensory Neuropathy |
4.3% |
| C-reactive Protein Increased |
3.8% |
| Ewing's Sarcoma |
2.9% |
| Extragonadal Primary Germ Cell Cancer |
2.9% |
| Urinary Retention |
2.9% |
| Brain Neoplasm |
2.4% |
| Desmoplastic Small Round Cell Tumour |
2.4% |
| Premedication |
2.4% |
| Prophylaxis Of Nausea And Vomiting |
2.4% |
|
| Vomiting |
18.9% |
| Interstitial Lung Disease |
11.3% |
| Pancytopenia |
9.4% |
| Treatment Related Secondary Malignancy |
9.4% |
| Ileus |
5.7% |
| Bronchopulmonary Aspergillosis |
3.8% |
| Lung Squamous Cell Carcinoma Stage Unspecified |
3.8% |
| Neutropenia |
3.8% |
| Pyrexia |
3.8% |
| Renal Disorder |
3.8% |
| Sepsis |
3.8% |
| Shock |
3.8% |
| Tumour Lysis Syndrome |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Chest Pain |
1.9% |
| Decreased Appetite |
1.9% |
| Gastric Stenosis |
1.9% |
| Hypomagnesaemia |
1.9% |
| Intestinal Obstruction |
1.9% |
| Malignant Neoplasm Progression |
1.9% |
|
| Concomitant |
| Drug Use For Unknown Indication |
10.5% |
| Nasopharyngeal Cancer Recurrent |
10.5% |
| Cough |
7.9% |
| Prophylaxis Of Nausea And Vomiting |
6.6% |
| Lung Neoplasm Malignant |
6.1% |
| Constipation |
5.2% |
| Gallbladder Cancer |
5.2% |
| Pain |
5.2% |
| Rash |
5.2% |
| Squamous Cell Carcinoma |
4.4% |
| Diabetes Mellitus |
3.9% |
| Lung Adenocarcinoma Stage Iv |
3.9% |
| Pleurodesis |
3.9% |
| Brain Cancer Metastatic |
3.5% |
| Pleural Mesothelioma Malignant |
3.5% |
| Prophylaxis |
3.5% |
| Insomnia |
3.1% |
| Breast Cancer |
2.6% |
| Breast Cancer Metastatic |
2.6% |
| Cancer Pain |
2.6% |
|
| Convulsion |
12.0% |
| Vocal Cord Paralysis |
12.0% |
| White Blood Cell Count Decreased |
12.0% |
| Wound Infection Staphylococcal |
8.0% |
| Renal Impairment |
6.0% |
| Aspiration |
4.0% |
| Back Pain |
4.0% |
| Cerebral Infarction |
4.0% |
| Headache |
4.0% |
| Hepatic Function Abnormal |
4.0% |
| Liver Disorder |
4.0% |
| Shock Haemorrhagic |
4.0% |
| Spinal Shock |
4.0% |
| Urinary Incontinence |
4.0% |
| Ventricular Fibrillation |
4.0% |
| Acute Respiratory Distress Syndrome |
2.0% |
| Drug Hypersensitivity |
2.0% |
| Drug Interaction |
2.0% |
| Fall |
2.0% |
| Grand Mal Convulsion |
2.0% |
|
